Value of tumour-infiltrating immune cells in predicting response to intravesical BCG in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis.

Mehdi Kardoust Parizi Shahrokh F Shariat Vitaly Margulis Keiichiro Mori Yair Lotan

Published in: BJU international (2020)

Based on these data, TIICs are significant predictors of RFS and response to BCG treatment in patients with NMIBC; therefore, incorporation of TIICs into risk stratification models may help patients and physicians in the clinical decision-making process in order to achieve the maximum possible benefit from BCG treatment.

Keyphrases

muscle invasive bladder cancer
decision making
end stage renal disease
chronic kidney disease
prognostic factors
big data
replacement therapy
smoking cessation
data analysis